Explore

Trendline Trendline
Longeveron Reports Q1 Financial Results and Strategic Updates

Longeveron Reports Q1 Financial Results and Strategic Updates

Longeveron Reports Q1 Financial Results and Strategic Updates
Trendline Trendline
Longeveron Reports Q1 2026 Financial Results and Strategic Developments in Stem Cell Therapy

Longeveron Reports Q1 2026 Financial Results and Strategic Developments in Stem Cell Therapy

Longeveron Reports Q1 2026 Financial Results and Strategic Developments in Stem Cell Therapy
Trendline Trendline
Savara Reports First Quarter Financial Results Highlighting MOLBREEVI Development Progress

Savara Reports First Quarter Financial Results Highlighting MOLBREEVI Development Progress

Savara Reports First Quarter Financial Results Highlighting MOLBREEVI Development Progress
Trendline Trendline
Palatin Technologies Reports Q3 2026 Financial Results and Business Progress

Palatin Technologies Reports Q3 2026 Financial Results and Business Progress

Palatin Technologies Reports Q3 2026 Financial Results and Business Progress
Trendline Trendline
Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates

Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates

Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates
Trendline Trendline
Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials

Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials

Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials
Trendline Trendline
Regenxbio's Duchenne Gene Therapy Shows Success, Prepares for FDA Submission

Regenxbio's Duchenne Gene Therapy Shows Success, Prepares for FDA Submission

Regenxbio's Duchenne Gene Therapy Shows Success, Prepares for FDA Submission
Trendline Trendline
PepGen Reports Financial Results and Advances in Neuromuscular Therapy Trials

PepGen Reports Financial Results and Advances in Neuromuscular Therapy Trials

PepGen Reports Financial Results and Advances in Neuromuscular Therapy Trials
Trendline Trendline
Kariya Pharmaceuticals and NeuraLight Collaborate on Brain-Focused GLP-1 Therapeutics for Neurodegenerative Diseases

Kariya Pharmaceuticals and NeuraLight Collaborate on Brain-Focused GLP-1 Therapeutics for Neurodegenerative Diseases

Kariya Pharmaceuticals and NeuraLight Collaborate on Brain-Focused GLP-1 Therapeutics for Neurodegenerative Diseases
Trendline Trendline
Palatin Reports Reduced Net Loss and Advances Obesity Programs

Palatin Reports Reduced Net Loss and Advances Obesity Programs

Palatin Reports Reduced Net Loss and Advances Obesity Programs
Trendline Trendline
Palatin Technologies Reports Q3 2026 Financial Results and Business Update

Palatin Technologies Reports Q3 2026 Financial Results and Business Update

Palatin Technologies Reports Q3 2026 Financial Results and Business Update
Trendline Trendline
Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026

Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026

Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026